Back to Results
First PageMeta Content
Piperazines / Biology / Organochlorides / Food and Drug Administration / Pharmacology / Clozapine / Antipsychotic / Duragesic / Hyperglycemia / Chemistry / Medicine / Atypical antipsychotics


FDA Patient Safety News: Show #28, June 2004
Add to Reading List

Open Document

File Size: 31,39 KB

Share Result on Facebook

Company

More Duragesic Patches / OraSure Technologies Inc. / bioMerieux Inc. / /

Country

United States / /

Event

Product Recall / Product Issues / FDA Phase / /

IndustryTerm

injection site / manufacturing lots / particular product / test device / healthcare workers / counterfeit product / genuine product / /

MedicalCondition

HIV / severe chronic pain / fatal embolisms / nausea / sleeplessness / drowsiness / obesity / patient developed phlebitis / HIV infection / shortness of breath / Hyperglycemia / diabetes / pain / infection / hyperosmolar coma / patient experienced muscle spasms / withdrawal symptoms / /

MedicalTreatment

Parenteral Nutrition / medication error / /

Organization

Food and Drug Administration / USP's Center for the Advancement of Patient Safety / FDA / /

/

Position

pharmacist / physician / /

Product

Duragesic / Risperdal / chorionic gonadotropin / dextrose / risperidone / certain cards / clozapine / Seroquel / Geodon / Abilify / fentanyl / GPS-107 / Zyprexa / Clozaril / HIV-1 / HIV-2 / Rapid / /

Technology

antibodies / GPS / http / /

URL

http /

SocialTag